New hope for hard-to-treat seizures: experimental drug enters final testing phase
Disease control
Recruiting now
This study tests whether an experimental drug called clemizole HCl can help reduce seizures in people with Lennox-Gastaut syndrome, a severe form of epilepsy that often starts in childhood. About 260 children and adults aged 2 to 55 will receive either the drug or a placebo along…
Phase: PHASE3 • Sponsor: Epygenix • Aim: Disease control
Last updated May 07, 2026 18:38 UTC